This is a U.S. news story, published by CNBC, that relates primarily to AstraZeneca news.
For more U.S. news, you can click here:
more U.S. newsFor more stocks trading & speculation news, you can click here:
more stocks trading & speculation newsFor more news from CNBC, you can click here:
more news from CNBCOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best business news, entertainment news, world news, and much more. If you like stocks trading & speculation news, you might also like this article about
flexibility Trump espouses. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest tariff plans news, reciprocal tariffs news, stocks trading & speculation news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
FlexibilityCNBC
•Business
Business & Economics
76% Informative
U.S. stocks end four-week losing streak.
AstraZeneca says it will invest $2.5 billion in a research and development center in China .
FedEx tumbles 6.5% after cutting its earnings outlook.
The SEC drops its long-running lawsuit against Ripple against the company.
VR Score
86
Informative language
90
Neutral language
64
Article tone
formal
Language
English
Language complexity
55
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links
